
North America Peritoneal Dialysis Equipment Market Outlook (2021-2031)
No. of Pages: 200 | Report Code: BMIPUB00032198 | Category: Life Sciences
No. of Pages: 200 | Report Code: BMIPUB00032198 | Category: Life Sciences
The North America peritoneal dialysis equipment market size is expected to reach US$ 1,469.8 million by 2031 from US$ 972.3 million in 2024. The market is estimated to record a CAGR of 6.5% from 2025 to 2031.
The peritoneal dialysis equipment market in North America is experiencing significant growth driven by growing demand for home-based dialysis, lower cost compared to in-center HD, and government support in developing regions. Patients’ preference for continuous ambulatory and automated peritoneal dialysis systems drives the market. Both systems are intended for patients who want a more flexible and quality-of-life-oriented treatment in the convenience of their own homes, like an in-center hemodialysis system. One major factor in the increasing preference for continuous ambulatory peritoneal dialysis or automated peritoneal dialysis systems is continuous innovation and change in peritoneal dialysis systems. Manufacturers are advancing automated PD cyclers, user interfaces, and remote patient monitoring. The recent advances seek to improve the treatment efficacy and safety, and give patients control over their treatment by enabling them to perform it at home. A favorable policy environment and public and private reimbursement schemes that acknowledge home dialysis therapies as patient-centric and cost-effective support the market’s anticipated growth. The 'consumables' segment of the market, particularly dialysis solutions, faces significant innovation challenges, especially in developing more biocompatible formulations aimed at improving patient outcomes and minimizing the risk of peritonitis.
Key segments that contributed to the derivation of the peritoneal dialysis equipment market analysis are product, application, and end user.
The North America peritoneal dialysis equipment market is segmented into the United States, Canada, and Mexico. The outlook for the North American peritoneal dialysis market is highly positive, with a clear trajectory toward increased adoption and innovation. The move to value-based healthcare models, where providers are compensated based on patient outcomes rather than the volume of services, has also forced healthcare systems to redirect their focus. PD is well-positioned to take advantage of one of the key strategic cost imperatives. Government programs and reimbursement policies in the United States support and endorse home dialysis therapies. The market will likely grow as the technology advances, for instance, portable and user-friendly devices for patients to stay mobile and independent, next-generation cyclers with artificial intelligence-enabled compliance, and choice for personalized treatment. As healthcare systems struggle to cope with the increasing prevalence of chronic kidney disease, there will be continued demand for cost-effective and operationally efficient solutions. Moreover, patient and caregiver safety training programs will remain critical to ensure effective PD settings at home.
Based on country, the North America peritoneal dialysis equipment market is segmented into the United States, Canada, and Mexico. The United States held the largest share in 2024.
The peritoneal dialysis market in North America is characterized quite differently across its major countries. The US is the dominant leader in the region with the peritoneal dialysis patient population and the use of state-of-the-art technology. The country has effective reimbursement policies that make home dialysis more accessible for patients, including favorable Centers for Medicare & Medicaid Services (CMS) policies. This has increased the number of incident PD patients and is likely to continue, as many federal-level healthcare initiatives support home dialysis. The US also has a robust healthcare infrastructure, with one of the highest burdens of chronic illness globally, making it a key North American market. Canada has a strong ESKD care system that incorporates an increasing focus on managing chronic diseases, including ESKD, which complements its universal healthcare system. Healthcare providers and patients specifically appreciate PD as it can minimize hospital visits that contribute to the overall disease burden and improve quality of life, a key metric within Canada's public component of health policy. In Mexico, more recently, greater public and private sector investment is being placed on renal care, with a growing acknowledgement of the burden of chronic kidney disease, in addition to expanding access to services. Several initiatives are underway to reform the treatment and approach to ESKD to improve patient access in Mexico's major urban centers. There are still challenges with creating adequate healthcare infrastructure and improving public awareness of PD; however, opportunities will continue to grow as there is a push to create healthcare policy that aims to directly improve patient outcomes, value efficiencies, and improve service delivery.
Report Attribute | Details |
---|---|
Market size in 2024 | US$ 972.3 Million |
Market Size by 2031 | US$ 1,469.8 Million |
Global CAGR (2025 - 2031) | 6.5% |
Historical Data | 2021-2023 |
Forecast period | 2025-2031 |
Segments Covered |
By Product
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
Fresenius Medical Care AG & Co KGaA; Baxter International Inc.; B. Braun SE; Nipro Corp; Medtronic Plc, Nikkiso Co Ltd, Teleflex Inc, Asahi Kasei Medical Co., Ltd., Terumo Corp, and DaVita Inc., are among the key players operating in the market. These players adopt strategies such as expansion, product innovation, and mergers and acquisitions to stay competitive in the market and offer innovative products to their consumers.
The following methodology has been followed for the collection and analysis of data presented in this report:
The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.
Business Market Insights conducts a significant number of primary interviews each year with industry stakeholders and experts to validate and analyze the data and gain valuable insights. These research interviews are designed to:
Primary research is conducted via email interactions and telephone interviews with industry experts across various markets, categories, segments, and sub-segments in different regions. Participants typically include:
The North America Peritoneal Dialysis Equipment Market is valued at US$ 972.3 Million in 2024, it is projected to reach US$ 1,469.8 Million by 2031.
As per our report North America Peritoneal Dialysis Equipment Market, the market size is valued at US$ 972.3 Million in 2024, projecting it to reach US$ 1,469.8 Million by 2031. This translates to a CAGR of approximately 6.5% during the forecast period.
The North America Peritoneal Dialysis Equipment Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Peritoneal Dialysis Equipment Market report:
The North America Peritoneal Dialysis Equipment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Peritoneal Dialysis Equipment Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Peritoneal Dialysis Equipment Market value chain can benefit from the information contained in a comprehensive market report.